Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Apr 24, 2019 4:20am
156 Views
Post# 29663212

RE:RE:Ok gentlemen we are good : )

RE:RE:Ok gentlemen we are good : )
they also have no intentions of taking PLI private as quoted in the release. So we will get our rights as expected.

You left out  SALP's weazel word "current" from the quote - that is not quite reassuring as you take it! They extended the loan to 2024 but they then CHANGED THEIR MIND JUST SOME 6 MONTHS LATER TO RESTRUCTURE US OUT. SO WHAT IF THEY CHANGE THEIR MIND AGain from their "current" thinking to take PLI private later on some 6 months down the road - say just before the FDA grants approval on PG for example?!
Bullboard Posts